Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002)

NCT01532973 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis, Viral, Human

Interventions

DRUG: Elbasvir
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC